Live Breaking News & Updates on Prnewswire Blacksmith Medicines Inc

Stay updated with breaking news from Prnewswire blacksmith medicines inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference

Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Al Iskandariyah , Zacharya Zimmerman , Amy Conrad , Eli Lilly , Basilea Pharmaceutica International Ltd , Roche Ltd , Prnewswire Blacksmith Medicines Inc , Company Lilly , Cyteir Therapeutics Inc , Annual Needham Healthcare Conference , Blacksmith Medicines , Hoffmann La Roche Ltd , Magnasci Ventures , Alexandria Venture ,

BLACKSMITH MEDICINES ANNOUNCES MERGER WITH FORGE THERAPEUTICS TO CREATE LEADING COMPANY DEVELOPING MEDICINES TARGETING METALLOENZYMES

/PRNewswire/ Blacksmith Medicines, Inc. (Blacksmith), and Forge Therapeutics (Forge), announce today that the companies have signed a definitive merger. ....

Al Iskandariyah , Amy Conrad , Zachary Zimmerman , Eli Lilly , Prnewswire Blacksmith Medicines Inc , Forge Therapeutics , Magnasci Ventures , Alexandria Venture Investments , Blacksmith Medicines , Media Contact ,

Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly

Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
-Blacksmith Medicines, a spin-out of Forge Therapeutics, is pioneering a novel metalloenzyme chemistry platform to create new immuno-oncology and inflammation medicines -
- Research collaboration combines Blacksmith s innovative chemistry platform with Lilly s research and development expertise for novel human metalloenzyme-targeted medicines; total potential deal value up to approximately $300M -
News provided by
Share this article
Share this article
SAN DIEGO, Jan. 8, 2021 /PRNewswire/ Blacksmith Medicines, Inc. (Blacksmith), a biotechnology company focused on creating novel medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, announced today that it has secured seed funding and has entered into a research collaboration with Eli Lilly and Company (Lilly). Lilly joins existing Blacksmith investors Evotec A.G., MP Healthcare Partne ....

Al Iskandariyah , Amy Conrad , Zachary Zimmerman , Eli Lilly , Roche Ltd , Basilea Pharmaceutica International Ltd , Company Lilly , Prnewswire Blacksmith Medicines Inc , Magnasci Ventures , Alexandria Venture , Forge Therapeutics , Blacksmith Medicines , Basilea Pharmaceutica International , Hoffmann La Roche Ltd , Forge Media Contact , ஆமி கான்ராட் , சக்கரி ஸிம்மர்மந் , எலி லில்லி , ரோச் லிமிடெட் , நிறுவனம் லில்லி , அலெக்ஸாண்ட்ரியா துணிகர , மோசடி சிகிச்சை , கறுப்பான் மருந்துகள் , ஹாஃப்மேன் லா ரோச் லிமிடெட் , மோசடி மீடியா தொடர்பு ,